← Browse entries

csp-2

C. elegans

Putative inactive caspase subunit p14

What the model saw

Gene: csp-2
Organism: Caenorhabditis elegans
Known functions: Putative inactive caspase subunit p14. caspase binding. cysteine-type endopeptidase activator activity. cysteine-type endopeptidase activity. cysteine-type peptidase activity. endopeptidase regulator activity. zymogen binding.
View unredacted entry
Putative inactive caspase subunit p14. caspase binding. cysteine-type endopeptidase activator activity. cysteine-type endopeptidase activity. cysteine-type peptidase activity. endopeptidase regulator activity. zymogen binding.

Solver output

Predicted influence
Pro-longevity
Confidence
62%
Mechanism
Cellular senescence
Reasoning

CSP-2 is annotated as a putative *inactive* caspase subunit (p14 domain) with cysteine-type endopeptidase activator activity, zymogen binding, and endopeptidase regulator activity. In C. elegans, the caspase pathway (CED-3/CED-4/CED-9) governs apoptosis; inactive or regulatory caspase-like proteins can act as dominant-negative modulators that dampen excessive caspase activation. By binding and sequestering active caspases or their zymogens, CSP-2 likely restrains aberrant apoptosis and caspase-driven cell death, thereby preserving tissue homeostasis and stem/somatic cell pools over time. Suppression of inappropriate apoptosis in post-mitotic tissues is associated with extended lifespan in C. elegans, as seen with loss-of-function in pro-apoptotic factors. The "inactive" catalytic designation is key: rather than driving cell death, CSP-2 functions as a brake on caspase cascades, placing it in a pro-longevity role analogous to anti-apoptotic regulators.

Key pathways
CED-3 caspase apoptosis pathwayzymogen/caspase regulatory bindingapoptosis suppression and tissue homeostasis
Longevity influence
Anti-longevity
Lifespan effect
Increase

GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.

Advisor judgment

Answer
Incorrect
Mechanism
Incorrect
Reasoning quality
2/5
Failure mode
Confident wrong
Notes

The model predicted pro_longevity but the ground truth is anti_longevity. The model's reasoning about CSP-2 acting as a dominant-negative inhibitor of caspases to suppress apoptosis and extend lifespan is plausible-sounding but incorrect. In reality, CSP-2 in C. elegans functions as an anti-longevity factor. The model's logic that "inactive caspase = brake on caspase cascades = pro-longevity" is flawed. CSP-2 actually promotes germline apoptosis and its activity is associated with reduced lifespan. The model's reasoning about cellular senescence as the mechanism class is also questionable for C. elegans biology. The confidence of 0.62 is moderate but the prediction is definitively wrong.

Raw API responses

solver

{
  "reasoning": "CSP-2 is annotated as a putative *inactive* caspase subunit (p14 domain) with cysteine-type endopeptidase activator activity, zymogen binding, and endopeptidase regulator activity. In C. elegans, the caspase pathway (CED-3/CED-4/CED-9) governs apoptosis; inactive or regulatory caspase-like proteins can act as dominant-negative modulators that dampen excessive caspase activation. By binding and sequestering active caspases or their zymogens, CSP-2 likely restrains aberrant apoptosis and caspase-driven cell death, thereby preserving tissue homeostasis and stem/somatic cell pools over time. Suppression of inappropriate apoptosis in post-mitotic tissues is associated with extended lifespan in C. elegans, as seen with loss-of-function in pro-apoptotic factors. The \"inactive\" catalytic designation is key: rather than driving cell death, CSP-2 functions as a brake on caspase cascades, placing it in a pro-longevity role analogous to anti-apoptotic regulators.",
  "confidence": 0.62,
  "key_pathways": [
    "CED-3 caspase apoptosis pathway",
    "zymogen/caspase regulatory binding",
    "apoptosis suppression and tissue homeostasis"
  ],
  "mechanism_class": "cellular_senescence",
  "longevity_influence": "pro_longevity"
}

advisor

{
  "notes": "The model predicted pro_longevity but the ground truth is anti_longevity. The model's reasoning about CSP-2 acting as a dominant-negative inhibitor of caspases to suppress apoptosis and extend lifespan is plausible-sounding but incorrect. In reality, CSP-2 in C. elegans functions as an anti-longevity factor. The model's logic that \"inactive caspase = brake on caspase cascades = pro-longevity\" is flawed. CSP-2 actually promotes germline apoptosis and its activity is associated with reduced lifespan. The model's reasoning about cellular senescence as the mechanism class is also questionable for C. elegans biology. The confidence of 0.62 is moderate but the prediction is definitively wrong.",
  "failure_mode": "confident_wrong",
  "answer_correct": false,
  "mechanism_correct": false,
  "reasoning_quality": 2,
  "ground_truth_questionable": false
}